Physician profile
Nader Fahimi
NPI 1346326956
$1,271.35
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.94 · 2020: $107 · 2021: $217 · 2022: $199 · 2023: $479 · 2024: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $496.51 | 2020-2023 | Mako, Tie-In |
| Smith+Nephew, INC. | $352.66 | 2019-2024 | Na, Goflo Pump, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $166.43 | 2019-2024 | Orthovisc, Monovisc |
| Anika Therapeutics, INC. | $109.29 | 2021 | |
| Avanos Medical | $68.72 | 2023-2024 | Genvisc 850 Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $36.82 | 2022 | |
| Si-Bone, INC. | $23.86 | 2021 | |
| Solventum Corporation | $17.06 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Fahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.